. 2019 Feb 13;20(8):976–984. doi: 10.1002/cbic.201800615
© 2019 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Scheme 2.
NTMT1 inhibitors.